How Sleep Labs Now Estimate Airway Collapsibility From a Standard Sleep Study Without Extra Equipment
Airway collapsibility measurement in a standard sleep study now runs on signals your lab already records
Your throat's collapse pressure can now be estimated from a study you may already have had, and three numbers already printed on your report get you part of the way tonight.
Airway Collapsibility Measurement From a Standard Sleep Study Explained
Yes. Your airway collapsibility can now be estimated from an ordinary overnight recording, with no extra sensor and no second night. An airway collapsibility measurement sleep study works by reading the airflow trace your lab already captures through the nasal pressure cannula, then back-calculating how readily your throat narrows. Software does the work, not hardware. This is the applied end of OSA endotypes, the shift from one diagnosis to four measurable traits.
One warning belongs at the top. In most of Europe the premise breaks at step one, because the EEG-bearing polysomnography these tools were validated on is not the test most patients receive. What your report can reveal depends on which study you had, and where. This page maps that, then hands you three numbers already printed on it.
- Collapsibility is derived from the airflow signal, not from added equipment.
- A full polysomnography with EEG gives the complete set of traits.
- A European home study still yields a usable collapsibility estimate.
What Existing Guides On This Topic Get Wrong
Two flaws run through almost every page ranking here.
The first flaw is geographic. The source literature assumes an attended, EEG-bearing in-lab study, because that is what American and Australian cohorts received. European pathways rarely deliver one. Telling you to request endotyping without checking whether your pathway produces the signals is advice you cannot act on.
The second flaw is stopping at the gold standard. A 2022 review indexed in PubMed Central, Critical to Know Pcrit, describes direct measurement as labour-intensive, time-consuming and not routinely measured in clinical practice. Then it leaves you there. It now omits the signal-derived methods that make airway collapsibility recoverable from a study you have probably already had.
A third gap: nothing on your report says which of three competing methods produced its numbers.
- Guides written for US practice assume a test most European patients never receive.
- The not-measurable-in-practice framing is now out of date.
- Nothing on your report says which method produced its numbers.
Pcrit, The Number Every Method Is Trying To Estimate
Pcrit is the pharyngeal critical closing pressure: the pressure at which airflow through your throat stops entirely. Picture the pharynx as a soft collapsible tube, an engineer's Starling resistor. That same 2022 PubMed Central review reports a normal adult pharyngeal Pcrit of −13.3 ± 3.2 cmH2O during sleep, and notes that nearly everyone with obstructive sleep apnoea sits above −5 cmH2O. The more positive the number, the floppier the airway.
Two versions exist. Passive Pcrit describes the airway with the muscles quiet. Active Pcrit describes it once pharyngeal dilator muscle tone is recruited, mainly through genioglossus muscle responsiveness.
Anatomy alone does not explain the disease. Eckert and colleagues, in the American Journal of Respiratory and Critical Care Medicine in 2013, studied 75 men and women across three nights: 36% had minimal genioglossus responsiveness, 37% a low respiratory arousal threshold, 36% high loop gain, and 28% carried multiple non-anatomical traits.
Measuring Pcrit directly means a CPAP drop-down titration protocol: pressure is lowered in steps until flow disappears. It is slow, and it often fails. The 2023 Frontiers in Sleep review reports it yields analysable data in only 16% to 70% of attempts, while routine-signal methods work on essentially every study. That reliability gap is why the field moved.
- Pcrit above −5 cmH2O indicates a collapsible pharynx (PubMed Central review, 2022).
- Passive and active Pcrit answer different clinical questions.
- Non-anatomical traits are present in most patients (AJRCCM, 2013).
Three Competing Routes To The Same Trait
All three turn a routine recording into an airway collapsibility measurement sleep study. They use signals your lab already records, and they differ in output and in validation.
| Method | Signals used | What it reports | Published validation |
|---|---|---|---|
| Report-level surrogates (SLEEP, 2022) | Event depth polysomnography, fraction of hypopnoeas, apnoea index versus hypopnoea index | Ranked collapsibility proxies | Versus gold-standard Pcrit in 57 patients plus 1,916 MESA participants: Vmin r = −0.54, event depth r = 0.49, hypopnoea fraction r = −0.46, apnoea index r = −0.46, Vpassive r = −0.38. Desaturation measures not significant. |
| Phenotyping using polysomnography (PUP) and PUPpy cloud endotyping | Nasal pressure cannula airflow signal, inspiratory flow limitation and flow shape analysis, respiratory inductance plethysmography | Vpassive (ventilation at eupneic drive), Vactive, Vmin (ventilation at nadir drive), upper airway compensation, loop gain LG1, arousal threshold | PUPpy matched the original across 38 studies: intraclass correlations 0.97 Vpassive, 0.97 Vactive, 0.96 loop gain LG1, 0.90 arousal threshold (SLEEP, 2020) |
| Interpretable machine-learning model | Standard clinical variables plus routine polysomnography variables | Categorised Pcrit, arousal threshold, loop gain, muscle responsiveness | In 52 participants: 65% accuracy for Pcrit, 56% arousal threshold, 40% loop gain, 41% muscle responsiveness (Annals of the American Thoracic Society, 2021) |
Collapsibility survives simplification best. Loop gain and muscle responsiveness degrade fastest when signals are stripped away, as the 2021 model's 40% and 41% accuracies show.
Is one night enough
Usually, yes. Strassberger and colleagues at the University of Gothenburg studied 67 patients with moderate-to-severe apnoea on two consecutive in-lab nights, publishing in Chest in 2023. Night-to-night intraclass correlations were 0.82 for collapsibility, 0.76 Vactive, 0.72 loop gain LG1 and 0.83 arousal threshold. They concluded one recording is enough.
Long-term stability differs. The 2023 Frontiers in Sleep review reports correlations of only 0.36 to 0.61 for the same traits six to seven years apart. Night-to-night variability of endotypic traits is small. Year-to-year drift is not. A report from six or seven years ago does not describe the airway you have now.
- Collapsibility is the endotype most reliably recovered from routine data.
- One night suffices for a current estimate (Chest, 2023).
- Traits drift substantially across years, so old reports expire.
Three Numbers Already On Your Report You Can Use Tonight
One trait needs no software at all. Edwards and colleagues published a three-item clinical score in the American Journal of Respiratory and Critical Care Medicine in 2014, built from figures a standard report already prints. It identifies the low arousal threshold endotype, linked to waking too easily and to poor tolerance of pressure therapy.
1Your AHI
Score one point if your apnoea-hypopnoea index is under 30 events per hour.
2Your nadir SpO2
Score one point if your lowest recorded oxygen saturation is above 82.5%. Look for nadir SpO2 or minimum saturation in the oximetry block.
3Your hypopnoea fraction
Divide your hypopnoea count by your total respiratory events. Score one point if more than 58.3% of events were scored as hypopnoeas rather than apnoeas.
- Find the three values. Our guide to reading your AHI, ODI and SpO2 report shows where each sits.
- Award one point per criterion met.
- A total of 2 or more indicates a low respiratory arousal threshold.
- Take the score to your next appointment as a question, never as a diagnosis.
The 2014 study reported that this cut-off correctly classified 84.1% of participants, with 80.4% sensitivity and 88.0% specificity. For most European patients tested at home, it is the only endotype estimate available.
The scoring rule that quietly flips your answer
Your score depends on how your lab counted hypopnoeas. The AASM manual recommends a 3% desaturation-or-arousal rule and lists the 4% rule as optional. The 3% rule produces a higher AHI and a different hypopnoea fraction. European labs and payers do not apply these uniformly, so one night scored under two conventions can move a patient between a low and a normal arousal threshold. Check your report's methods line first.
- AHI, nadir SpO2 and hypopnoea fraction give you a usable estimate now.
- Two or more points indicates a low arousal threshold (AJRCCM, 2014).
- The 3% versus 4% hypopnoea rule can change the result.
What An Airway Collapsibility Measurement Sleep Study Reveals Across Europe
What an airway collapsibility measurement sleep study can tell you depends on which test your country runs first. The ERS 2023 technical standard defines the type III limited-channel study that dominates European practice as a three-to-seven-sensor recording acquired without any electroencephalographic data. No EEG means no scored cortical arousals, which blocks the arousal-threshold trait by the conventional route. The clinical score above is the workaround.
| Country | Usual first-line test | EEG recorded | What you can obtain |
|---|---|---|---|
| United Kingdom | Home oximetry, then home respiratory polygraphy. NICE guideline NG202 (2021) places polysomnography third or fourth line for OSAHS | No | Airway collapsibility surrogates plus the clinical arousal-threshold score. Polysomnography only if polygraphy is negative and symptoms continue. |
| France | Polygraphie ventilatoire first, polysomnographie second, for SAOS (syndrome d'apnées obstructives du sommeil). Assurance Maladie reimburses 70% of the tariff on prescription, with the ticket modérateur usually met by your mutuelle | Polygraphy no, polysomnography yes | Base de remboursement around 119 euros for polygraphie (about 145 euros under OPTAM) and around 200 euros for polysomnographie. Cost is one reason patients are steered to polygraphy first. |
| Germany | Kardiorespiratorische Polygraphie within a formal Stufendiagnostik, then Schlaflabor polysomnographie | Frequently yes | Polygraphy is not permitted alongside pulmonary, psychiatric, neurological or neuromuscular comorbidity, so more patients reach full polysomnography and Germany produces proportionally more endotypeable studies. |
| Spain, Italy and most EU states | Limited-channel respiratory polygraphy under the ERS type III standard; full polysomnography is not first-line | Usually no | Flow-derived collapsibility surrogates and the clinical arousal-threshold score. |
European norms are coming from European data. The European Sleep Apnoea Database (ESADA), an ERS Clinical Research Collaboration founded in 2007 under an EU COST Action, has recruited close to 50,000 patients across roughly 30 academic sleep centres. Published normative tables still lean on American cohorts. The 2023 Frontiers in Sleep review gives collapsibility values of 71.5 ± 15.6%, 77.5 ± 14.4% and 62.0 ± 22.8% of eupnoeic ventilation across three cohorts, showing how far the reference range moves between populations.
- Type III studies carry no EEG, so arousals cannot be scored (ERS, 2023).
- German pathways yield more full polysomnography than UK or French ones.
- Normative ranges vary widely between cohorts, so context matters.
Why Nasal Breathing Decides Whether Any Of This Is Computable
Every scalable airway collapsibility method derives ventilation from the nasal pressure cannula airflow signal. Switch to mouth breathing and that signal stops representing your ventilation. The 2023 Frontiers in Sleep review devotes a named section to oral breathing because it invalidates the flow trace these calculations depend on.
The physiology explains the size of the problem. A 2026 Frontiers in Sleep expert consensus on nasal patency reports that the internal nasal valve accounts for roughly 50% to 60% of total upper airway resistance, that a 15% to 20% reduction in valve radius markedly increases airflow resistance, and that mouth breathing in obstructive sleep apnoea raises the work of breathing about 2.5-fold. Nasal patency is not a comfort issue here. It is a precondition.
Keeping the oro-nasal breathing route nasal is a practical goal, not a cosmetic one. A soft stent that holds the nasal valve and nasopharynx open during sleep is one mechanically direct way to do it. No such device measures or phenotypes anything.
- Mouth breathing can make the flow signal unscoreable (Frontiers in Sleep, 2023).
- The internal nasal valve carries most upper airway resistance (2026 consensus).
- Flag habitual mouth breathing to your lab before the recording night.
What Airway Collapsibility Measurement On Your Sleep Study Changes
This is where every ranking page goes quiet. Here is the logic clinicians apply.
1Mild collapsibility, shallow events, high hypopnoea fraction
Non-pressure options earn their place here. Mandibular advancement device responder prediction is most favourable, and positional therapy and nasal measures are worth trying.
2Severe collapsibility, deep events, high apnoea index
A high therapeutic CPAP pressure acts as a collapsibility proxy in the same direction. This profile predicts oral appliance failure. Stay with pressure therapy and discuss surgical or hypoglossal nerve stimulation candidacy.
3Low arousal threshold
This trait is associated with poor tolerance of pressure therapy. Knowing it early reframes difficulty as physiology rather than personal failure.
4High loop gain
Ventilatory control instability contributes to events that anatomy alone does not explain. It points toward specialist review.
Collapsibility says how easily the airway closes. It does not say where. Drug-induced sleep endoscopy (DISE) answers that second question, and European ENT clinics use it to map the collapse site.
The same fault line decides whether a nasal stent makes sense. Back2Sleep is a CE-certified Class I soft silicone intranasal stent from a French company in Paris, made for snoring and mild-to-moderate obstructive sleep apnoea, with a four-size starter kit at around 39 euros, no prescription and a 30-day money-back window. It fits profile one. If your report points to profile two, deep events and a low hypopnoea fraction, you are not a stent candidate and should stay with the therapy you have.
- Severe collapsibility predicts non-response to oral appliances.
- A low arousal threshold flags likely difficulty with pressure therapy.
- Collapsibility answers how easily, not where, the airway closes.
How To Ask Your Sleep Centre, And Why It Is Not On Your Report
You need vocabulary, not a request form. Ask whether the centre's scoring software computes endotypic traits, and name the technology: phenotyping using polysomnography, its cloud implementation PUPpy, and the endophenotyping modules sold with recording platforms. Ask whether the traits can be released as a research output, usually the only form in which they exist.
Expect a qualified answer. The Icelandic sleep-diagnostics manufacturer whose cloud platform runs PUPpy stated in 2023 that its endophenotyping analysis is used for research purposes only. Its supporting work in 509 patients produced three clusters, high collapsibility, low arousal threshold and low upper airway compensation, with pressure-therapy compliance falling from 79.1% at three months to 51.1% at twelve.
The regulatory reason is European and specific. Under EU MDR Rule 11, software that monitors physiological processes is Class IIa, so a Notified Body must assess the quality system and technical documentation before a CE mark applies. From 2026, AI-enabled devices at Class IIa or above carry a parallel obligation under the EU AI Act. Running the analysis as research output avoids that pathway. That is why the numbers exist but stay off your clinical report.
Precision sleep medicine is arriving unevenly. An airway collapsibility measurement sleep study is already computable from recordings European labs make tonight. The maths is settled, the signals are on tape, and the obstacle is regulatory rather than scientific.
- Name PUP, PUPpy and endophenotyping analysis when you call your centre.
- The leading European analysis is research-use-only, not a CE-marked output.
- EU MDR Rule 11 and the EU AI Act explain the gap on your report.
What Back2Sleep Users Say
Frequently Asked Questions
Can you measure airway collapsibility from a normal sleep study without extra equipment?
Yes. Software estimates airway collapsibility from the airflow signal a routine study already records, with no catheter or added sensor. Validation against gold-standard Pcrit in 57 patients found event depth, hypopnoea fraction and apnoea index the best clinical surrogates (SLEEP, 2022). Your lab may compute these without printing them.
How do I know if I have a low arousal threshold from my sleep study report?
Use the three-item score published in the American Journal of Respiratory and Critical Care Medicine in 2014. Award one point each for an AHI under 30, a nadir SpO2 above 82.5%, and more than 58.3% of events scored as hypopnoeas. Two or more points suggests a low arousal threshold, correct in 84.1% of participants.
Can a home sleep apnoea test measure airway collapsibility, or do I need a full in-lab polysomnography?
A home respiratory polygraphy can support collapsibility surrogates from flow, but not the arousal-threshold trait. The ERS 2023 technical standard defines type III devices as three-to-seven-channel recordings with no EEG, so cortical arousals cannot be scored. Full polysomnography with EEG yields the complete trait set, including loop gain.
How much does a polysomnographie cost in France and is it reimbursed?
L'Assurance Maladie reimburses 70% of the tariff on medical prescription, with the remaining co-payment usually covered by your mutuelle. The base de remboursement is around 200 euros for polysomnographie and around 119 euros for polygraphie ventilatoire, rising to about 145 euros under the OPTAM option. Cost helps explain why polygraphy comes first.
Does mouth breathing make my sleep study results inaccurate?
It can. Scalable endotyping methods derive ventilation from the nasal pressure cannula, so oral breathing produces a flow signal that may be unscoreable. A 2026 Frontiers in Sleep expert consensus notes the internal nasal valve carries roughly 50% to 60% of upper airway resistance. Tell your technician before the recording night.
Is one night of testing enough to measure my sleep apnoea endotype?
Usually yes. Researchers at the University of Gothenburg studied 67 patients on two consecutive nights and reported intraclass correlations of 0.82 for collapsibility and 0.83 for arousal threshold, publishing in Chest in 2023. They concluded a single night suffices. Traits do drift across years, so an old report may no longer apply.
Does airway collapsibility predict whether a mandibular advancement device will work for me?
It helps. Severe collapsibility, seen as deep events and a high apnoea index, predicts poorer response to oral appliances. Mild collapsibility with a high hypopnoea fraction identifies the group for whom non-pressure options are realistic. Ask your sleep physician to interpret your report rather than acting on the pattern alone.
Why does my sleep report show an AHI but no information about why my airway collapses?
Because the analysis is usually research output, not a clinical result. Under EU MDR Rule 11, software that monitors physiological processes is Class IIa and needs Notified Body assessment before CE marking, and from 2026 AI-enabled devices carry a parallel EU AI Act obligation. Labs compute the traits without reporting them.
Ready for quieter nights? Discover the Back2Sleep starter kit and find the right fit for you.
Not sure if you are at risk? Take our sleep risk screening to find out in just a few minutes.
Want to learn how it works? Explore the Back2Sleep nasal stent designed for comfortable, effective relief.